Gallbladderpar Liquid
NDC Package 44911-0256-1
Package Information
Gallbladderpar (carduus marianus, fel tauri, taraxacum officinale, chelidonium majus, lycopodium clavatum, magnesia phosphorica, natrum sulphuricum, nux vomica, phosphorus, sanguinaria canadensis, gallbladder (suis)) liquids is for temporary relief of symptoms of flatulence, constipation, belching and abdominal discomfort; burning and itching due to hemorrhoids.****These statements are based upon traditional homeopathic practice. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0256.
Identification & Billing
Clinical Specifications
- BOS TAURUS BILE 6 [hp_X]/mL
- CHELIDONIUM MAJUS WHOLE 12 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 12 [hp_X]/mL
- MILK THISTLE 3 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- SANGUINARIA CANADENSIS ROOT 12 [hp_X]/mL
- SODIUM SULFATE 12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL
- SUS SCROFA GALLBLADDER 30 [hp_X]/mL
- TARAXACUM OFFICINALE 6 [hp_X]/mL
- Allergens - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0256 - Gallbladderpar
- 44911-0256-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0256 - Gallbladderpar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0256-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Gallbladderpar, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains bos taurus bile; chelidonium majus whole; lycopodium clavatum spore; magnesium phosphate, dibasic trihydrate; milk thistle; phosphorus; sanguinaria canadensis root; sodium sulfate; strychnos nux-vomica seed; sus scrofa gallbladder; taraxacum officinale as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on September 03, 2015. The current certification is valid through December 31, 2026.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911025601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.